Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 54Lymphoma 40Lymphoma, Large B-Cell, Diffuse 28Lymphoma, Non-Hodgkin 21Hodgkin Disease 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Osteosarcoma 17Testicular Neoplasms 15Burkitt Lymphoma 15Leukemia 14Lymphoma, Large-Cell, Immunoblastic 13Lymphoma, Follicular 13Ovarian Neoplasms 12Lymphoma, Mantle-Cell 12Neuroectodermal Tumors, Primitive, Peripheral 11Testicular Germ Cell Tumor 10Liposarcoma 10Histiocytoma, Malignant Fibrous 10Hemangiosarcoma 10Fibrosarcoma 10Sarcoma, Synovial 9Rhabdomyosarcoma 9Neurofibrosarcoma 9Lymphoma, Large-Cell, Anaplastic 9Leiomyosarcoma 9Teratoma 8Recurrence 8Neuroblastoma 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8

Interventions

Dexamethasone 22Ondansetron 20Aprepitant 20Palonosetron 17Granisetron 11Calcium Dobesilate 8Therapeutics 7Olanzapine 6dexamethasone acetate 5Doxorubicin 5Cyclophosphamide 5casopitant 4Acupressure 4netupitant 3dolasetron 3Yoga 3Vincristine 3Radiotherapy 3Dronabinol 3Analgesia 3ginger extract 2fosaprepitant 2dexamethasone 21-phosphate 2Tropisetron 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Prochlorperazine 2Metoclopramide 2Mesna 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Nausea × Ifosfamide × Clear all
NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed
47 enrolled 6 charts
Sarcoma

Nausea, Neoplasms, Sarcoma, Vomiting

NCT00410488 2013-03-22

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled 5 charts
Sarcoma

Nausea, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡